Skip to content

Assessment of CD276 and HER2 Immunohistochemical Expression in Bladder Carcinoma: A Comparison Between Pathologist Interpretation and Aperio Digital Software

· 0 citations · 32 references

TL;DR

A comparison of the immunohistochemical expression of (CD276) and (HER2) in various bladder tissue sections from Iraqi patients with UBC by pathological and aperio digital revealed the Digital Aperio Program was inaccurate for interpreting the immunohistochemistry scoring for both markers.

View source

Similar papers

Open access Sep 2026

Comparative Analysis of Two HER2 Immunohistochemistry Scoring Methods in Breast Carcinoma: Implications for HER2-Low Classification

Background: Breast cancer is one of the most common carcinomas worldwide and remains the leading cause of cancer-related death among women. A key biomarker used to guide treatment decisions in breast carcinoma is the expression of human epidermal growth factor receptor 2 (HER2). However, the assessment of HER2 expressi...

Citra Dewi, Sandria Sandria, Novasari Novasari · 0 citations
Open access Oct 2026

Immunohistochemical Expression of p16 in Breast Carcinoma and its Correlation with Clinicopathological Parameters

Background: Breast carcinoma is the most prevalent malignancy among women globally. The tumour suppressor protein p16 (INK4a) plays a pivotal role in cell cycle. Aberrant p16 expression has been linked to distinct molecular subtypes of breast carcinoma. This study aimed to evaluate the immunohistochemical (IHC) express...

R. Venkatesh, S. Aishwarya, V.Eswari · 0 citations
Open access Oct 2026

Programmed Death-Ligand 1 Immunohistochemical Expression in Invasive Urothelial Carcinoma of the Bladder: Association with Lymphovascular Invasion

Clinical significance of PD-L1-positive cases in this study were identified only in tumors with lympho-vascular invasion, and because of incomplete clinical staging data and the limited sample size, the clinical significance of this observation remains uncertain and requires further validation in larger studies.

L. I. Laksmi, C. Mariedina, Betty Betty · 0 citations
Open access Oct 2026

Prognostic Value of PD-L1 and Its Correlation with GATA3, CK5/6, and CK14 Expression in Muscle-Invasive Bladder Cancer.

BACKGROUND Muscle-invasive bladder cancer (MIBC) is an aggressive urothelial carcinoma with poor outcomes. This study investigated programmed death ligand 1 (PD-L1) expression and its association with key immunohistochemical markers (GATA3, CK5/6, CK14) and overall survival (OS). METHODS We analyzed formalin-fixed, p...

S. Sangkhathat, Kanet Kanjanapradit, Tanan Bejrananda et al. · 0 citations
Open access Sep 2026

Clinicopathological Study of CK19 Expression in Head and Neck Squamous Cell Carcinoma and Its Association with Tumor Grading: A Cross-Sectional Study.

CK19 expression is significantly associated with poor tumor differentiation in HNSCC, particularly by WHO grading, supporting its potential as a prognostic biomarker that may enhance grading accuracy and inform treatment strategies.

Akhil Kumar, Vibhuti Thukral, R. Kalra · 0 citations
Open access Nov 2026

A Clinicopathological Study of CK5/6 and EGFR Expression in Triple-Negative Breast Cancers

Background and Objective: Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer. Cytokeratin 5/6 (CK5/6) and epidermal growth factor receptor (EGFR) are basal markers that may be associated with tumour characteristics. This study aimed to evaluate CK5/6 and EGFR expression in...

Balaji P. M., G. Raghavan, A. P · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.